MIT working on hydrogel tech for battlefield wounds; BioDelivery Sciences and Endo discuss candidate with FDA;

> MIT researcher Brad Olsen, along with two co-workers, is working to develop an injectable hydrogel for use on battlefield wounds. Story

> BioDelivery Sciences International ($BDSI) and Endo Pharmaceuticals ($ENDP) met with the FDA on July 15 to discuss BEMA Buprenorphine for severe pain management. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.